Skip to main content
KISSEI PHARMACEUTICAL CO.,LTD. logo

KISSEI PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4547 ISIN · JP3240600001 T Manufacturing
Open in API
Filings indexed 80 across all filing types
Latest filing 2022-06-23 Audit Report / Informat…
Country JP Japan
Listing T 4547

About KISSEI PHARMACEUTICAL CO.,LTD.

https://www.kissei.co.jp/e_contents/

Kissei Pharmaceutical Co., Ltd. is a research-driven company engaged in the discovery, development, manufacturing, and sale of pharmaceutical products. The company concentrates its research and development investments in key therapeutic areas, including urology, renal diseases and dialysis, and rare or intractable diseases. Its broader product portfolio also addresses conditions in metabolic and endocrinological, obstetrics and gynecological, and ophthalmic fields. Committed to creating innovative medicines, Kissei aims to contribute to global health by addressing unmet medical needs. The company also operates in the health foods sector.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. This is a standard Japanese regulatory filing (often accompanying an Annual Securities Report/Yukashoken Hokokusho) where the representative confirms the accuracy of the report's contents. Since it is a specific regulatory filing required by law and does not fit into the other categories like 10-K or IR, it is classified as a Regulatory Filing (RNS). FY 2022
2022-06-23 Japanese
内部統制報告書－第77期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. This type of document is a standalone regulatory filing concerning audit and internal control standards, which fits the 'Audit Report / Information' category.
2022-06-23 Japanese
有価証券報告書－第77期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the standard header information for such filings, including the fiscal year (77th term, 2021-04-01 to 2022-03-31), the filing date (2022-06-23), and the regulatory body (Kanto Local Finance Bureau). The presence of extensive XBRL-like tags and financial data confirms it is the full annual report rather than an announcement. FY 2022
2022-06-23 Japanese
四半期報告書－第77期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report
2022-02-10 Japanese
訂正報告書（大量保有報告書・変更報告書）
Major Shareholding Notification Classification · 100% confidence The document is a 'Large Volume Holding Report' (大量保有報告書) filed in Japan, which is a regulatory requirement when an entity's shareholding in a listed company crosses certain thresholds. This corresponds to the 'Major Shareholding Notification' category in the provided schema.
2021-12-06 Japanese
変更報告書
Major Shareholding Notification
2021-11-24 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.